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Examinations on the chemical specificity of skin hypersensitiveness of guinea
pigs to arsphenamines have been made by Sulzberger and F. A. Simon and other
investigators (see below). Additional detailed studies of this question seemed
to be indicated to the present author, especially in relation to former similar
examinations in man.
REVIEW AND DISCUSSION OF THE LITERATURE
Frei and II. L. Mayer (1) applied a series of 32 different substances intracutaneously to
three male patients who had recovered from generalized exfoliative neosalvarsan dermatitis
and to six normal persons.3 All three cases of dermatitis displayed hypersensitiveness of
varying degree not only to arsphenamines but to one member of another group of aromatic
1 From the Division of Pulmonary Diseases, Montefiore Hospital for Chronic Diseases,
New York, N. Y. Aided by a grant from the Dazian Foundation for Medical Research.
2 Former articles in this series are: "Further Studies in Arsphenamine Hypersensitiveness
in Guinea Pigs. I. Cutaneous and Anaphylactic Responses to Old Arsphenamine and to
Neoarsphenamine after Sensitization with Old Arsphenamine," by Wilhelm Frei and Marion
B. Sulzberger, Jour. Invest. Derm. 1: 191, June, 1938; and "Further Studies in Arsphen-
amine Hypersensitiveness in Guinea Pigs. II. Attempts at Experimental Specific Sensiti-
zation of Guinea Pigs to Quinine, to Acetyl Salicylie Acid, and to Barbital, with and without
Preceding or Concomitant Arsphenamine Sensitization." Jour. Invest. Derm., 4: 111,
April, 1941.
Cannon and Karelitz (2) observed a high percentage of non-specific inflammations in
intracutaneous arsphenamine tests in man, obtaining most of the inflammatory reactions
with dilutions of 1:100 (neoarsphenamine) and 1:200 (neutralized old arsphenamine, silver
arsphenamine). The same neoarsphenamine concentration was employed by Olin (3) in
recent examinations.
Frei and H. L. Mayer, influenced by their own previous experiences, did not use stronger
neoarsphenamine concentrations than 0.15:100 for intracutaneous testing, and prepared
their dilutions with physiologic saline solution instead of with distilled water. They read
and evaluated the tests, like all tests with allergens of originally irritating character, by
actually comparing the reactions of dermatitis cases and control persons, tested at the same
time with the same freshly prepared solutions and examined after 24 and 48 hours.
The present author, who had used intracutaneous arsphenamine tests in man almost ex-
clusively for scientific and not for practical purposes, later abandoned them entirely because
of the possibility of sensitization or activation respectively—on this point being in accord
with Moore, Woo, Robinson and Gay (4); Klauder (5); Cannon and Karelitz (2); Schoch
(6b), and other investigators.
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trivalent arsenicals, an arsine oxide, and also, to certain aromatic pentavalent arsenicals.
Two of the patients gave positive tests even to one of three aliphatic arsenical compounds.
None of them reacted specifically to inorganic tn- or pentavalent arsenicals, or to any
compound of the benzene group, more or less related to arsphenamirLe, but not containing
arsenic. According to Frei and R. L. Mayer, their own findings didL not indicate that all
cases of generalized exfoliative arsphenamine dermatitis must have the same chemical
basis; as a matter of fact, some differences were also observed even among these three cases.
(For further details, discussion and literature, see Frei and R. L. Mayer; see also Gamier
(7); Moore, Woo, Robinson and Gay (4); Puente and Cordiviola (8); Cannon and Karelitz
(2); et al.)
After discovery of the method of artificial specific sensitization of man to arsphenamine
(Frei and R. L. Mayer (1); Frei (9a); Nathan and Munk (ba); Kaplun and Moreinis (11);
Ensbruner (12); Hanaoka (13)); Frei4 (9a) in a short preliminary experiment with neo-
salvarsan (Hoechst), and Nathan and Grundmann (lob), in more extended series with
myosalvarsan (Hoechst), tested persons who were artificially sensitized to these preparations,
comparing them with normal controls. The results of these tests were similar to, though
not entirely identical with the observations obtained in generalized exfoliative neosalvarsan
dermatitis by Frei and R. L. Mayer.
All persons reacted specifically to various kinds of arsphenamine, most of them to arsine
oxide, some to a lesser degree to diverse aromatic pentavalent arsenicals, and none to ali-
phatic or inorganic arsenicals, or to aromatic compounds without arsenic (see Nathan and
Grundmann (lob)).
It should also be noted that in recent investigations of Chargin and Leifer (17), activa-
tion of fixed eruptions due to arsphenamines was produced not only by various arsphenamines
but also in many cases by arsine oxide and by sOme aromatic pentavalent arsenical com-
pounds.
When the method of artificial sensitization to arsphenamines was applied to guinea pigs
(Frei (9b); Sulzberger (18a); et al), intracutaneous testing for chemical specificity was
performed in these animals (Sulzberger and F. A. Simon (18d); Cormi.a (14a); Miescher and
Schnitzer (10) et al.). Here specific reactions were obtained only with various arsphena-
mines, but not with aromatic pentavalent arsenicals. Williamson (20) mentioned positive
reactions elicited by mapharsen, an arsine oxide.
The question arises as to whether variations of qualitative or of quantitative character were
responsible for these differences in the results obtained.
There is no doubt that qualitative differences exist between the allergic state of man
afflicted with generalized exfoliative arsphenamine dermatitis and that of man artificially
sensitized by intracutaneous injections of arsphenamine. For, hypersensitiveness of the
latter kind predisposes clinically mainly to eruptions of the erythemato-morbilliform-
urticarial type and not to those of the dermatitis type (Nathan (lOc); Kaplun and Moreinis
(11); discussed by Frei (Oc)).5
Several American investigators, studying the sensitization of man to arsphenamines by
intracutaneous injections, obtained either 1) different results (Moore, Woo, Robinson and
Gay (4)) or 2) negative results (Cannon and Karelitz (2); Schoch (6b)). Cormia (14b)
offers the hypothesis that this "common failure to produce sensitization experimentally in
human beings may be partially due to a failure to duplicate collateral factors which have
been found important in animal experimentation." (Sulzberger and Mayer; Sulzberger
and Simon.) There are, however, other possible explanations also. On the question of
sensitization to arsphenamines by patch test see Beerman (15) and Stokes (16).
Frei at the time of his discovery of the method of artificial sensitization of man to
arsphenamine by intracutaneous injections, first believed that the hypersensitiveness pro-
duced by this procedure was identical with the hypersensitiveness of cases of generalized
exfoliative arsphenamine dermatitis. Later, he changed his opinion as a result of the
experiments conducted in the meantime by the above-named investigators.
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On the other hand, there is a strong similarity of skin symptoms in man artificially sensi-
tized to arsphenamines by intracutaneous injections compared to those in guinea pigs treated
in the same way. In both man and guinea pigs flare-ups may appear on the site of the first
injections, as a sign of acquired hypersensitiveness. Such hypersensitiveness may also
develop without previous flare-up; this happens frequently in animals, rarely in man.
Furthermore, in the first extensive experiments by Frei (9b) on guinea pigs, distinct cry-
thematous macules were observed in some of the most strongly sensitized animals, when
reinjected intracardially nine or ten days after intracutaneous sensitization to neosal-
varsan (Hoechst). These macules were localized mainly hut not exclusively in the sur-
roundings of the flare-ups and might, to a certain degree, be compared with the morbilliform
erythemas described by Nathan (bc) in man sensitized to myosalvarsan (Hoechst). Kap-
lun and Moreinis (11) even observed universal morbillif arm exanthemas in one of their
guinea pig series.
In contrast to these close relationships, it is doubtful whether the anaphylactic type of
arsphenamine hypersensitiveness in guinea pigs is based on the same immunological mech-
anism as the cutaneous type, although both types may develop after a single intracutaneous
injection of old arsphenamine. (Landsteiner and Jacobs (21); Frei and Sulzberger (22).)
The reason for this doubt is that animals sensitized by old arsphenamine give strong skin
reactions to old arsphenamine as well as to neoarsphenamine, but respond with anaphylactic
symptoms only to the first compound (Frei and Sulzberger (22)). This argumentation
supports the opinion expressed by Cormia (14c) as a result of his findings in recent experi-
ments.
The other possibility mentioned before is that variations of quantitative character were the
cause of the different results obtained in skin testing of the various groups. Although a
series of three cases of generalized exfoliative neosalvarsan dermatitis is rather small for
subdividing, it may be mentioned that the two severe cases gave not only stronger reactions
to arsphenamines than the mild one, but reacted to a greater number of pentavalent aro-
matic arsenicals and, in contrast to the mild case, also reacted to one of the aliphatic arseni-
cals. This scanty evidence, however, increases in significance because of the fact that
analogous observations have been made by Nathan and Grundmann (lOb) on persons arti-
ficially sensitized to myosalvarsan. Of their nine cases, the one which showed the highest
degree of allergy toward arsphenamines was also the only one to react to all three of the
aromatic pentavalent arsenicals tested. Such observations indicate that in arsphenamine
hypersensitiveness the intensity of the attergic state has some influence on the range of posi-
tive reactions.6
There is another quantitative factor too, which one must not neglect. Frei and H. L.
Mayer, whose tests demonstrated a somewhat broader base of sensitivity than those of
Nathan and Grundmann, frequently increased the concentration of their test substances
when the first reactions were negative. Nathan and Grundmann used only a single concen-
tration, corresponding in weight either to their myosalvarsan concentration or to one-tenth
Df this amount.
The possibility exists that the same quantitative factors were responsible for the small range
of positive reactions in guinea pigs sensitized to arsphenamines. The hypersensitiveness
produced in guinea pigs by neoarsphenamine or some other arsphenamine compounds is
sometimes rather low, especially under conditions explored by Sulzberger and co-workers
(23). The only exception is old arsphcnamine, which was not employed in those experi-
ments because its strong sensitizing power was not known at that time. Furthermore, the
test substances used in the former experiments on guinea pigs were mostly applied in one single
concentration, equivalent, either in arsenic content, or in weight, to the customary neo-
6 See also recent examinations of Schoch, Alexander and Long (be): Mild cases of neo-
arsphenamine dermatitis tolerated mapharsen treatment after recovery and gave negative
patch tests to mapharsen. Severe cases exhibited recurrences of dermatitis after very
small mapharsen doses and reacted positively to mapharsen patch tests.
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arsphenamine concentration (0.15:100) introduced by Frei for tests in man and guinea pigs
sensitized to this preparation itself. The concentrations of substances more or less related
to the sensitizing compound were not increased in those guinea pig experiments when
specific reactions failed to appear. They were occasionally decreased when disturbing non-
specific reactions were produced by this concentration.
Observations on artificial conjugated antigens have shown that "antibodies react most
strongly to the homologous antigen, but also regularly, with graded affinity, on chemically
relatedsubstances" (Landsteiner (24)). Suchgradationsmay,tosomeextent, alsoplay a role
in arsphenamine hypersensitiveness, and should be taken into consideration in skin testing
for specificity. If one wishes to go deeper into the chemical relationship of the arsphen-
amine allergy, it would be advisable, therefore, to increase the hypersensitiveness of the test
animals, as well as the concentration of the test substances, as much as possible. Distinct
non-specific irritations should, of course, be avoided.
GENERAL PROCEDURE
Therefore, in the following experiments on guinea pigs, old arsphenamine, as
the strongest available allergen of the arsphenamine group, was employed for
sensitization, and the highest, well-tolerated concentrations of the various test
substances were applied for intracutaneous testing. In the case of most of the
substances, the initial concentration used for testing was either equimolar to
the customary test concentration of old arsphenamine (0.15:100) or was based
on former experiences of the author or other investigators. If the first injection
of a test substance did not give a positive result and, on the other hand, was not
followed by any non-specific irritation, the concentration was increased until
the non-specific inflammatory effect obtained in the control animals had about
the same low grade as the mild primary reaction of non-sensitized guinea pigs
to the above mentioned test concentration of old arsphenamine. If the irri-
tating effect was stronger, the concentration was decreased. Table 1 demon-
strates this procedure in the case of sodium cacodylate, tested in control animals.
The table demonstrates, at the same time, a difficulty frequently encountered
in these experiments. On two occasions, ten per cent solutions of sodium cacody-
late were applied to non-sensitized guinea pigs. They produced a mild irritation
one day, and a very strong one, with central necrosis, another day. This
inconstancy of the irritating effect was still more conspicuous with the use of some
other arsenic preparations, for example, mapharsen, sodium arsenate and espe-
cially, sodium arsenite. Cormia (14a) discovered that the same concentration
of potassium arsenite, which in experiments of Sulzberger and F. A. Simon (18d)
produced a severe irritating effect and therefore, had to be reduced by these
investigators, was well tolerated in his experiments. He believed "that the
present group of pigs either had comparatively insensitive skins, or that the
preparation itself is a varying factor." Of course, these two conditions may
play a role in the interpretation of this phenomenon. However, one can also
find inconstancies of the irritating effects in treating members of one batch of
guinea pigs with the same brand of sodium arsenite on different days. Further-
more, the same control animals which reacted insignificantly to one intracutane-
ous injection of sodium arsenite have, several days later, reacted to another
injection of the same strength with necrosis. The impression arose that this
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phenomenon might also be connected with certain weather conditions. Hot
weather, perhaps especially when accompanied by high humidity, seems to
increase the necrotizing effect of these arsenic preparations on the skin of guinea
pigs. This would be in accordance with the experience of the present author,
that, in human therapy, disturbances produced by some arsenic preparations,
for instance, by solutio Fowleri, are more frequent in summer than in other
seasons.
TABLE 1
Sodium cacodylate, applied in increasing concentrations intracutaneously to non-sensitized
guinea pigs
Experiments of former investigators have demonstrated that low concentrations of
sodium cacodylate (0.087:100) do not elicit any allergic skin reaction in guinea pigs sensi-
tized to arsphenamine (neoarsphenamine). On the other hand, one was led to expect from
the experiences in human therapy, that sodium cacodylate might be used in much higher
concentrations without damaging the skin. Therefore, skin testing of control animals
with this preparation was done with concentrations increasing gradually from one to ten
per cent. Finally, a solution of eight per cent was chosen for allergy tests—a concentra-
tion ninety-three times higher than that used by previous investigators. Intracutaneous
injections of this high concentration, although accompanied by visible signs of pain, were
followed only by very insignificant inflammation in control animals.
Solutions were prepared in distilled water immediately before intracutaneous injec-
tions. Three to six non-sensitized guinea pigs were used for each solution. The injected
amount was 0.1 c.c. Reactions were read after one and two days.
The following terms are used in the table:
None: No visible irritation was produced.
Insignificant: Irritation was less pronounced than the mild irritation produced by
the test concentration of 0.15. per cent of old arsphenamine in non-sensitized
guinea pigs.
Moderate: Irritation was equal to that produced by 0.15 per cent of old arsphenamine.
Strong: Irritation was stronger than this irritation.
Concentration of
sodium cacodylate
in per cent 1 1.5 2 5 6.5 8 10 10
Irritating effect on
the skin of non-
sensitized guinea
pigs None None None Insignifi-
cant
Insignifi-
cant
Moder-
ate
Moder-
ate
Strong
The preceding has set forth the principles upon which the following investiga-
tions on specificity of arsphenamine hypersensitiveness were based.
EXPERIMENTAL DATA
A first series of experiments on guinea pigs sensitized to old arsphenamine,
and on non-sensitized controls, was made in order to obtain a general survey of
the field. The results are listed in table 2.
In a second series of experiments on guinea pigs sensitized to old arsphenamine,
and on non-sensitized controls, intracutaneous testing of several of the sub-
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TABLE 2
Tests on guinea pigs sensitized to old arsphenamine, and on non-sensitized controls
White virgin guinea pigs of 300 to 500 g. were used for sensitization to old arsphenamine.
Sensitization was effected by a single intracutaneous injection of 0.1 c.c. of a 0.15 per cent
aqueous solution of old arsphenamine Winthrop. The injections were followed by small
inflammatory, pale pink, slightly elevated lesions of four to five mm. in diameter, which
diminished or disappeared after a few days and were for the most part, replaced by a so'
called flare-up. All of the animals injected in this series proved sensitized to old arsphen-
amine when reinjected with a solution of the original strength after four weeks.
The test substances, listed below, were dissolved in distilled water immediately before
use. Four to six sensitized animals, and three non-sensitized guinea pigs of one batch
were then injected intracutaneously, at the same time, with 0.1 c.c. of each solution. In
some instances, as in mapharsen, tryparsamide, sodium cacodylate, sodium arsenate and
sodium arsenite, testing was repeated three to five times in various concentrations. Reac-
tions were read after one and two days.
The following signs are used in the table:
++ Strong reactions were observed in sensitized guinea pigs, consisting of large
inflammatory papules with central necrosis.
+ + —+ Comparatively strong reactions were observed, consisting of somewhat
smaller papules, accompanied by central necrosis in some of the sensitized
animals.
+ Reactions were less than those previously mentioned and without central
necrosis, but definitely stronger than the small inflammatory lesions of the
control animals.
(+) Reactions of the majority of sensitized animals were slightly stronger
thaii those of the non-sensitized ones.
No definite decision could be made as to whether there were differences in
the reactions of sensitized and non-sensitized animals.
— No differences were observed in the reactions of sensitized and non-sensitized
animals.
ScBSTJ.CE CONCENTRATION
per ceni
Old arsphenamine 0.15 ++
Neoarsphenamine 0.15 ++
Sulfarsphenamine . 0.25 + + —+
Silver arsphenamine 0.08 + + —+
Mapharsen 0.022 (+)
Tryparsamide 4.0 (+)
Sodium cacodylate 6.5
Sodium arsenite 0.035 —
Sodium arsenate 0.2
o-aminophenol hydrochloride 0.2 —
p-aminophenol hydrochloride 0.2
p-aminoazobenzene hydrochloride Almost 0.1 (saturated solu- —
tion)
Azobenzene Saturated in boiling water
Acetyl salicylic acid About 0.17 (half saturated
solution)
Barbital About 0.38 (half saturated
solution)
Quinine hydrochloride 0.2
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stances, examined in the first series, was repeated, and other preparations were
added to the list. In these experiments testing was done under special precau-
tions (see below) and on a greater number of animals than was used in the first
series.
ANALYSIS OF RESULTS
According to the results listed in tables 2 and 3, guinea pigs sensitized with
old arsphenamine, display skin hypersensitiveness not oniy to the sensitizing
preparation, but at the same time, to a greater or lesser degree, to other arsphen-
amines. The majority of tested animals also gave slightly positive reactions to
a member of another group of aromatic trivalent arsenicals, to mapharsen—an
arsine oxide. Furthermore, positive reactions were produced by three aromatic
pentavalent arsenicals, namely, atoxyl, tryparsamide, and sodium p-hydroxy-
phenylarsonate, though to a lesser degree than by arsphenamines. These
positive reactions to aromatic pentavalent arsenicals were obtained only when
higher concentrations were used than had been used in experiments of former
investigators, whereas concentrations corresponding to those formerly applied,
gave the same negative results as previously. This fact permits the interpreta-
tion that it was not so much the change to old arsphenamine as sensitizing agent,
as the increase of the test concentrations that was responsible for these positive
results.
The reactions of sensitized guinea pigs were questionable or negative to three
aliphatic arsenicals, sodium cacodylate, solarson and n-propylarsonic acid, and
to the tn- and pentavalent inorganic arsen'icals, sodium arsenite and sodium
arsenate. Also seven aromatic chemicals, not containing arsenic, were examined;
among these were four azo compounds and amino products of the benzene group
as substances related to the organic part of arsphenamine, and two heterocyclic
compounds, quinine hydrochloride and barbital, as substances not related to
arsphenamine. In contrast to the benzene derivatives containing arsenic, none
of the azo and amino products without arsenic gave any trace of a positive
reaction; nor did any of the other organic substances tested.
The report thus far, contains some facts already established by previous in-
vestigations, and some others hitherto not known. That sensitization of guinea
pigs to one arsphenamine preparation produces hypersensitiveness to various
members of the arsphenamine group has been demonstrated by experiments of
R. L. Mayer (25); Sulzberger and F. A. Simon (18d); Frei and Sulzberger (22);
and Miescher and Schnitzer (19). That this hypersensitiveness extends to
mapharsen has been mentioned by Williamson (20). That it does not extend
to inorganic arsenicals has been stated by Sulzberger and F. A. Simon and by
Cormia (14a). On the other hand, specific skin reactions to aromatic penta-
valent arsenicals have not been produced previously in guinea pigs sensitized to
arsphenamine. Aliphatic arsenicals have been tested only in the case of a single
preparation, sodium cacodylate, and in very low concentrations of that prepara-
tion. Also organic compounds related to arsphenamine, but not containing
arsenic, have not yet been examined to any noticeable extent. Sulzberger and
TABLE 3
Further tests on guinea pigs sensitized to old arsphenamine, and on non-sensitized control
animals
White virgin guinea pigs of about 400 g. were sensitized to old arsphenamine by a single
intracutaneous injection of 0.1 c.c. of a 0.15 per cent solution of arephenamine Winthrop
in saline solution. The injections were followed by slightly elevated pale pink papules of
three to four mm. in diameter and, a few days later, by flare-ups in all cases. All animals
proved to be sensitized to old arsphenamine when reinjected with a solution of the original
brand and strength after four weeks. Both arsphenamine injections were done on the
backs of the animals.
The test substances were dissolved in saline solution (see Frei and R. L. Mayer; Frei;
Frei and Sulzberger), since under this condition their irritating effect was less pronounced
than in aqueous solution, and, consequently, higher concentrations could be applied to the
animals. Only in very high, hypertonic concentrations, as prepared from tryparsamide
and sodium cacodylate, was there no difference in the irritating effect, either with or with-
out the addition of sodium chloride. In these cases, aqueous, as well as saline solutions
were used for testing. All solutions were freshly prepared from sterilized triple distilled
water. Only glassware, syringes, and cannulas (26 gauge) which never before had come
in contact with arsphenamines were employed in the experiments of this series (see Schoch6).
Each solution was tested intracutaneously in one batch of nine sensitized and ten non-
sensitized animals at the same time. Injections were performed on the flanks, at least one
day after very exact shaving. The amount injected was 0.1 c.c. Reactions were read
after one and two days.
The signs used to indicate the results in this table are the same as those used in Table 2.
At the end of this experiment, all animals were tested to old arsphenamine. The animals
previously sensitized to this preparation gave positive, and the control animals negative
reactions.
SUBSTA5CE coNCENTRATIoN RESULT
per cent
Old arsphenamine 0.15 --+
Atoxyl 0.15
Atoxyl 1.0 +
Atoxyl 1.2 +
Tryparsamide 0.2 —
Tryparsamide 9.0 +
Tryparsamide* 9.0, +
sodium p-hydroxyphenylarsonate 0.1 —
Sodium p-hydroxyphenylarsonate Almost 1.0 (hot
solution)
saturated (+)
Sodium p_hydroxyphenylarsonate* Almost 1.0 (hot
solution)
saturated (+)
Sodium cacodylate 6.5 —
Sodium cacodylate 8.0
Sodium cacodylate* 8.0 —
Solarson (chlorarsenol) t 1.0 —
n-propylarsonic acid Almost 0.5 (hot
solution)
saturated
Sodium arsenite 0.17 —
Sodium arsenate 1.2 —
o-aminophenol hydrochloride 0.5 —
p-aminophenol hydrochloride 0.6 —
p-aminoazobenzene hydroch1oride 0.12 —
Azobenzene 0.032
* Solution was prepared in distilled water instead of in saline solution.
t Commercially prepared solutions were used.
Solutions were prepared by diluting tw per cent alcoholic solutions in saline.
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F. A. Simon have already stressed the necessity of examinations of the latter
kind. They also obtained negative results in testing aminopyrine on guinea
pigs sensitized to neoarsphenamine.
The results of the present experiments on guinea pigs are similar to those ob-
tained by Frei and R. L. Mayer in examinations on human beings who had
recovered from generalized exfoliative neosalvarsan dermatitis. The conclusion
drawn by Frei and Mayer in 1927 with regard to their cases is, to a great extent,
also valid for the skin hypersensitiveness of guinea pigs to old arsphenamine.
This conclusion was "The hypersensitiveness was neither directed toward
arsenic nor toward the organic part of arsphenamine, nor exclusively toward
arsphenamines, but was directed toward organic arsenical compounds" (transla-
tion). A single different finding was that in guinea pigs no aliphatic arsenical
gave a positive reaction. On this, as well as on other points, the results on
guinea pigs are in complete accordance with the findings of Nathan and Grund-
mann on man sensitized by intracutaneous injections of myosalvarsan. Differences
in details are, of course, inevitable; especially in arsphenamine hypersensitiveness,
where considerable variations can be found in the range of specificity in man
as well as in guinea pigs. These differences could, undoubtedly, be further
reduced, if, in man, higher concentrations of test Solutions were to be used than
those chosen by Nathan and Grundmann. In principle, in both man and guinea
pigs, the skin hypersensitiveness produced by intracutaneous injections of ars-
phenamine, has been directed not only to are phenamines, but, to a lesser degree,
also to arsine oxide and aromatic pentavalent arsenicals. It is most remarkable
that analogous observations have been made by Chargin and Leifer (17) in their
studies on activation of fixed arsphenamine eruptions.
It may be questioned as to whether the arsphenamine hypersensitiveness of
guinea pigs and its chemical specificity is worth such painstaking minute exam-
inations. Of course, these experiments have no direct value in relation to clinical
practice. Antisyphilitic treatment of persons hypersensitive to arsphenamine
is not decided by animal experiment but by practical experience. For instance,
in spite of the fact that intracutaneous injections of high concentrations of
tryparsathide into guinea pigs are followed by local allergic reactions, distur-
bances produced by the customary antisyphilitic tryparsamide therapy are rare
in patients hypersensitive to arsphenamine (see cases of E. Epstein (26); Golz
(27); Franks and Fisher (28)) Y
On the other hand, the eminent practical importance of arsphenamine in-
juries demands the most extensive and intensive examinations, independent of
their immediate practical value. Furthermore, there are still many unsolved
problems in the field of arsphenamine allergy; and the exact knowledge of the
close connections between skin allergy of man and of guinea pigs to arsphena-
mine, may lead to a successful approach to the solution of one or another of these
problems by animal experiment. At the same time, these experiments on ars-
phenamine hypersensitiveness of guinea pigs demonstrate a procedure which
On mapharsen therapy in cases of neoarsphenamine hypersensitiveness see Schoch,
Alexander and Long (6c) et al.
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should be applied in general to examinations on chemical specificity of allergic
skin reactions; the procedure of cautiously increasing the concentrations of the
test solutions as previously described in this paper.
SUMMARY AND CONCLUSIONS
Intracutaneous testing of guinea pigs sensitized with old arsphenamine, and
of non-sensitized control animals, gave the following results: the skin hyper-
sensitiveness of the sensitized guinea pigs was not directed toward arsenic, nor
toward the organic part of arsphenamines, nor exclusively toward arsphena-
mines, but it was directed in varying degree toward aromatic arsenicals in general.
These results are similar to the findings of Frei and R. L, Mayer in some cases
of generalized exfoliative neosalvarsan dermatitis, and are almost identical with
those of Nathan and Grundmann, obtained in man experimentally sensitized
with myosalvarsan. Furthermore, they also correspond to observations made
by Chargin and Leifer in their studies on activation of fixed arsphenamine
eruptions.
In skin tests on specificity of an allergic state, the concentrations of test
substances should be varied within reasonable limits, in order also to embrace
low grades of specific affinity.
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